Get the Stockscreener App
1.63
2.98%
-0.05
Pre-market:
1.63
Bluejay Diagnostics Inc stock is traded at $1.63, with a volume of 62,440.
It is down -2.98% in the last 24 hours and down -8.94% over the past month.
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.
See More
Previous Close:
$1.68
Open:
$1.65
24h Volume:
62,440
Relative Volume:
0.04
Market Cap:
$2.73M
Revenue:
-
Net Income/Loss:
$-8.59M
P/E Ratio:
-0.00119
EPS:
-1373
Net Cash Flow:
$-9.25M
1W Performance:
-10.93%
1M Performance:
-8.94%
6M Performance:
-62.79%
1Y Performance:
-99.00%
1-Day Range:
$1.61
$1.67
1-Week Range:
$1.61
$1.85
52-Week Range:
$1.46
$188.50
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
Name
Bluejay Diagnostics Inc
Sector
Industry
Phone
(978) 631-0152
Address
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Compare BJDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BJDX
Bluejay Diagnostics Inc
|
1.63 | 2.73M | 0 | -8.59M | -9.25M | -1,373.00 |
|
ABT
Abbott Laboratories
|
132.28 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
SYK
Stryker Corp
|
373.37 | 147.15B | 23.22B | 2.86B | 3.58B | 7.40 |
|
BSX
Boston Scientific Corp
|
101.73 | 146.97B | 17.55B | 2.03B | 2.72B | 1.37 |
|
MDT
Medtronic Plc
|
86.17 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
73.27 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Bluejay Diagnostics Inc Stock (BJDX) Latest News
Bluejay Diagnostics (BJDX) Stock Skyrockets Over 44% on Nasdaq in Explosive Short-Term Rally - Daily Chhattisgarh News
Why Rent the Runway Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket - Benzinga
Bluejay Diagnostics Initiates SYMON-II Clinical Study - TipRanks
Bluejay Diagnostics advances sepsis test, plans FDA filing By Investing.com - Investing.com South Africa
Bluejay Diagnostics (BJDX) Provides 2025 Mid-Year Business Updat - GuruFocus
Bluejay Diagnostics (BJDX) Provides 2025 Mid-Year Business Update | BJDX Stock News - GuruFocus
Bluejay Diagnostics advances sepsis test, plans FDA filing - Investing.com Australia
Bluejay Diagnostics Provides Mid-Year Business And Corporate Update - marketscreener.com
Bluejay Diagnostics Slashes Workforce to Just 5 Employees as Cash Burns, Despite Promising Sepsis Trial Data - Stock Titan
Bluejay Diagnostics (NASDAQ:BJDX) Stock Price Up 1.2% – Here’s Why - Defense World
Bluejay Diagnostics announces CTO departure By Investing.com - Investing.com South Africa
Bluejay Diagnostics Announces CTO Departure Effective May 30 - TipRanks
Bluejay Diagnostics announces CTO departure - Investing.com Australia
Pre-market Movers: IXHL, KLRS, HCTI, DOCS... - RTTNews
Bluejay Diagnostics, Inc. SEC 10-Q Report - TradingView
Bluejay Diagnostics Inc (BJDX) Stock: A Comprehensive 52-Week Review - investchronicle.com
Bluejay Diagnostics Inc (BJDX)’s stock price range in the last year - uspostnews.com
BJDX stock touches 52-week low at $1.6 amid steep annual decline - Investing.com Canada
BJDX stock touches 52-week low at $1.6 amid steep annual decline By Investing.com - Investing.com South Africa
BJDX stock touches 52-week low at $2.22 amid sharp annual decline By Investing.com - Investing.com South Africa
BJDX stock touches 52-week low at $2.22 amid sharp annual decline - Investing.com India
Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting - The Manila Times
Breakthrough Sepsis Test Could Predict Patient Mortality Risk, New Study Reveals - Stock Titan
Small Cap Stocks To Watch NowApril 7th - MarketBeat
US Markets Rebound As Global Trade Tensions Persist - Finimize
United States shares lower at close of trade; Dow Jones Industrial Average down 0.84% - Investing.com India
Bluejay Diagnostics slumps after raising $3.7M through warrant exercise deal - MSN
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.84% - Investing.com
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.84% - Investing.com UK
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
BJDX stock touches 52-week low at $3.01 amid steep annual decline By Investing.com - Investing.com South Africa
BJDX stock touches 52-week low at $3.01 amid steep annual decline - Investing.com
Dow Jumps Over 1,100 Points; US Small Business Sentiment Falls In March - Benzinga
Wall Street Attempts Recovery From Tariff-Driven Losses as US Equity Futures Rise Pre-Bell - TradingView
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Jack Kellogg Called The Market Bottom - timothysykes.com
Bluejay Diagnostics Plunges Premarket After Investors Agree to Exercise Warrants at Reduced Price - marketscreener.com
Bluejay Diagnostics Sinks Premarket Following Investor Agreement to Exercise Warrants at 'Reduced' Price - marketscreener.com
Bluejay Diagnostics enters into agreement with institutional investors - Medical Buyer
Why Levi Strauss Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
Bluejay Diagnostics Raises $3.7M Through Warrant Deal, Stock Slides After-Hours While Retail Interest Surges - NewsBreak: Local News & Alerts
Bluejay Diagnostics (BJDX) Secures $3.7M Through Warrant Exercis - GuruFocus
Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds - The Manila Times
Bluejay Diagnostics Announces Entry Into Warrant Inducement Transaction For Approximately $3.7 Million In Gross Proceeds - marketscreener.com
Bluejay Diagnostics Raises Fresh $3.7M Capital: New Warrant Deal Strengthens Balance Sheet - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Vermilion Energy Inc. Confirms First Quarter 2025 Release Date and Filing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders - Yahoo Finance
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
'Magnificent 7' stocks continue getting hammered as Trump tariffs drag markets lower - Yahoo Finance
Bluejay Diagnostics Inc Stock (BJDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):